Latest News about Initiation
Recent news which mentions Initiation
Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock
October 16, 2024
From Benzinga
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
October 16, 2024
From Benzinga
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
October 16, 2024
From Benzinga
Burke & Herbert A 'Hidden Gem'? Analyst Highlights 'Underappreciated' Earnings Potential
October 16, 2024
From Benzinga
This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
October 15, 2024
From Benzinga
From Benzinga
This PG&E Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
October 14, 2024
From Benzinga
Amazon's AI-Driven AWS Growth To Power Outperformance: Analysts
October 11, 2024
From Benzinga
Google Set To Lead AI Wave, Sees Positive Outlook Ahead Despite Antitrust Actions Impact
October 11, 2024
From Benzinga
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential
October 11, 2024
From Benzinga
From Benzinga
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
October 11, 2024
From Benzinga
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
October 10, 2024
From Benzinga
This Builders FirstSource Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
October 10, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.